nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—SLCO2B1—Niacin—atherosclerosis	0.0815	0.111	CbGbCtD
Dinoprostone—SLCO2B1—Rosuvastatin—atherosclerosis	0.0693	0.0947	CbGbCtD
Dinoprostone—SLCO2B1—Pravastatin—atherosclerosis	0.063	0.0862	CbGbCtD
Dinoprostone—ABCC4—Rosuvastatin—atherosclerosis	0.0529	0.0724	CbGbCtD
Dinoprostone—SLC22A11—Pravastatin—atherosclerosis	0.0517	0.0707	CbGbCtD
Dinoprostone—SLC22A7—Pravastatin—atherosclerosis	0.0493	0.0674	CbGbCtD
Dinoprostone—SLCO1A2—Rosuvastatin—atherosclerosis	0.038	0.0519	CbGbCtD
Dinoprostone—SLCO1B1—Ezetimibe—atherosclerosis	0.0358	0.049	CbGbCtD
Dinoprostone—SLCO1B1—Rosuvastatin—atherosclerosis	0.0358	0.049	CbGbCtD
Dinoprostone—SLCO1A2—Simvastatin—atherosclerosis	0.0353	0.0483	CbGbCtD
Dinoprostone—SLCO1A2—Pravastatin—atherosclerosis	0.0345	0.0472	CbGbCtD
Dinoprostone—SLCO1A2—Lovastatin—atherosclerosis	0.0345	0.0472	CbGbCtD
Dinoprostone—SLCO1B1—Simvastatin—atherosclerosis	0.0333	0.0455	CbGbCtD
Dinoprostone—SLCO1B1—Lovastatin—atherosclerosis	0.0326	0.0446	CbGbCtD
Dinoprostone—SLCO1B1—Pravastatin—atherosclerosis	0.0326	0.0446	CbGbCtD
Dinoprostone—SLC22A8—Pravastatin—atherosclerosis	0.0301	0.0411	CbGbCtD
Dinoprostone—SLC22A6—Pravastatin—atherosclerosis	0.021	0.0287	CbGbCtD
Dinoprostone—PTGIR—artery—atherosclerosis	0.00245	0.0664	CbGeAlD
Dinoprostone—Pregnancy—Lovastatin—atherosclerosis	0.0023	0.0252	CcSEcCtD
Dinoprostone—Pregnancy—Simvastatin—atherosclerosis	0.00215	0.0236	CcSEcCtD
Dinoprostone—PTGIR—endothelium—atherosclerosis	0.00207	0.0561	CbGeAlD
Dinoprostone—PTGIR—blood vessel—atherosclerosis	0.00191	0.0517	CbGeAlD
Dinoprostone—PTGER4—connective tissue—atherosclerosis	0.00164	0.0444	CbGeAlD
Dinoprostone—Laryngitis—Niacin—atherosclerosis	0.00156	0.017	CcSEcCtD
Dinoprostone—PTGER4—cardiovascular system—atherosclerosis	0.00143	0.0387	CbGeAlD
Dinoprostone—PTGER3—connective tissue—atherosclerosis	0.00139	0.0376	CbGeAlD
Dinoprostone—Hypertonia—Rosuvastatin—atherosclerosis	0.00135	0.0148	CcSEcCtD
Dinoprostone—Inflammation—Ezetimibe—atherosclerosis	0.00132	0.0145	CcSEcCtD
Dinoprostone—PTGER2—adipose tissue—atherosclerosis	0.00128	0.0347	CbGeAlD
Dinoprostone—Inflammation—Simvastatin—atherosclerosis	0.00126	0.0138	CcSEcCtD
Dinoprostone—PTGER4—adipose tissue—atherosclerosis	0.00126	0.0341	CbGeAlD
Dinoprostone—Skin discolouration—Niacin—atherosclerosis	0.00124	0.0136	CcSEcCtD
Dinoprostone—SLC51B—liver—atherosclerosis	0.00121	0.0328	CbGeAlD
Dinoprostone—HPGDS—connective tissue—atherosclerosis	0.0012	0.0325	CbGeAlD
Dinoprostone—Hearing impaired—Pravastatin—atherosclerosis	0.00116	0.0127	CcSEcCtD
Dinoprostone—Vaginal inflammation—Niacin—atherosclerosis	0.00112	0.0123	CcSEcCtD
Dinoprostone—PTGER3—adipose tissue—atherosclerosis	0.00107	0.0289	CbGeAlD
Dinoprostone—Vaginal infection—Niacin—atherosclerosis	0.00106	0.0116	CcSEcCtD
Dinoprostone—HPGDS—cardiovascular system—atherosclerosis	0.00104	0.0283	CbGeAlD
Dinoprostone—Cramps of lower extremities—Niacin—atherosclerosis	0.00103	0.0113	CcSEcCtD
Dinoprostone—Hot flush—Ezetimibe—atherosclerosis	0.000994	0.0109	CcSEcCtD
Dinoprostone—Menopausal symptoms—Ezetimibe—atherosclerosis	0.000986	0.0108	CcSEcCtD
Dinoprostone—Hypertonia—Niacin—atherosclerosis	0.000984	0.0108	CcSEcCtD
Dinoprostone—PTGIR—connective tissue—atherosclerosis	0.000979	0.0265	CbGeAlD
Dinoprostone—HPGDS—adipose tissue—atherosclerosis	0.000921	0.025	CbGeAlD
Dinoprostone—Deafness—Pravastatin—atherosclerosis	0.000897	0.00981	CcSEcCtD
Dinoprostone—SLC51A—liver—atherosclerosis	0.000867	0.0235	CbGeAlD
Dinoprostone—Hot flush—Pravastatin—atherosclerosis	0.000857	0.00938	CcSEcCtD
Dinoprostone—Cramp muscle—Lovastatin—atherosclerosis	0.000854	0.00935	CcSEcCtD
Dinoprostone—PTGFR—adipose tissue—atherosclerosis	0.000852	0.0231	CbGeAlD
Dinoprostone—PTGIR—cardiovascular system—atherosclerosis	0.000851	0.0231	CbGeAlD
Dinoprostone—Menopausal symptoms—Pravastatin—atherosclerosis	0.00085	0.0093	CcSEcCtD
Dinoprostone—CYP11A1—connective tissue—atherosclerosis	0.000846	0.0229	CbGeAlD
Dinoprostone—Cramp muscle—Ezetimibe—atherosclerosis	0.000838	0.00917	CcSEcCtD
Dinoprostone—Cramp muscle—Simvastatin—atherosclerosis	0.000799	0.00874	CcSEcCtD
Dinoprostone—Urinary retention—Niacin—atherosclerosis	0.000775	0.00848	CcSEcCtD
Dinoprostone—Pharyngitis—Rosuvastatin—atherosclerosis	0.000768	0.00841	CcSEcCtD
Dinoprostone—SLCO1C1—adipose tissue—atherosclerosis	0.000753	0.0204	CbGeAlD
Dinoprostone—PTGIR—adipose tissue—atherosclerosis	0.000751	0.0203	CbGeAlD
Dinoprostone—Cramp muscle—Pravastatin—atherosclerosis	0.000722	0.0079	CcSEcCtD
Dinoprostone—Arrhythmia—Rosuvastatin—atherosclerosis	0.000692	0.00757	CcSEcCtD
Dinoprostone—Sweating increased—Pravastatin—atherosclerosis	0.000675	0.00739	CcSEcCtD
Dinoprostone—SLCO3A1—adipose tissue—atherosclerosis	0.000663	0.018	CbGeAlD
Dinoprostone—SLCO2A1—adipose tissue—atherosclerosis	0.000656	0.0178	CbGeAlD
Dinoprostone—CYP11A1—adipose tissue—atherosclerosis	0.000649	0.0176	CbGeAlD
Dinoprostone—HPGDS—liver—atherosclerosis	0.000646	0.0175	CbGeAlD
Dinoprostone—Pharyngitis—Ezetimibe—atherosclerosis	0.000639	0.00699	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000609	0.00667	CcSEcCtD
Dinoprostone—Flushing—Lovastatin—atherosclerosis	0.000609	0.00666	CcSEcCtD
Dinoprostone—Myocardial infarction—Pravastatin—atherosclerosis	0.000606	0.00663	CcSEcCtD
Dinoprostone—SLCO4A1—adipose tissue—atherosclerosis	0.000604	0.0164	CbGeAlD
Dinoprostone—ABCC5—adipose tissue—atherosclerosis	0.0006	0.0163	CbGeAlD
Dinoprostone—PTGFR—liver—atherosclerosis	0.000597	0.0162	CbGeAlD
Dinoprostone—Flushing—Ezetimibe—atherosclerosis	0.000597	0.00654	CcSEcCtD
Dinoprostone—Chills—Lovastatin—atherosclerosis	0.000589	0.00644	CcSEcCtD
Dinoprostone—Cough—Rosuvastatin—atherosclerosis	0.000588	0.00644	CcSEcCtD
Dinoprostone—Angiopathy—Ezetimibe—atherosclerosis	0.000584	0.00639	CcSEcCtD
Dinoprostone—Immune system disorder—Ezetimibe—atherosclerosis	0.000581	0.00636	CcSEcCtD
Dinoprostone—Myalgia—Rosuvastatin—atherosclerosis	0.000574	0.00628	CcSEcCtD
Dinoprostone—Arthralgia—Rosuvastatin—atherosclerosis	0.000574	0.00628	CcSEcCtD
Dinoprostone—Flushing—Simvastatin—atherosclerosis	0.00057	0.00623	CcSEcCtD
Dinoprostone—Back pain—Lovastatin—atherosclerosis	0.000552	0.00605	CcSEcCtD
Dinoprostone—Pharyngitis—Pravastatin—atherosclerosis	0.000551	0.00603	CcSEcCtD
Dinoprostone—Chills—Simvastatin—atherosclerosis	0.000551	0.00603	CcSEcCtD
Dinoprostone—CYP19A1—connective tissue—atherosclerosis	0.00055	0.0149	CbGeAlD
Dinoprostone—Muscle spasms—Lovastatin—atherosclerosis	0.000549	0.00601	CcSEcCtD
Dinoprostone—Back pain—Ezetimibe—atherosclerosis	0.000542	0.00593	CcSEcCtD
Dinoprostone—Muscle spasms—Ezetimibe—atherosclerosis	0.000539	0.00589	CcSEcCtD
Dinoprostone—Vision blurred—Lovastatin—atherosclerosis	0.000538	0.00589	CcSEcCtD
Dinoprostone—Tremor—Lovastatin—atherosclerosis	0.000535	0.00586	CcSEcCtD
Dinoprostone—PTGIR—liver—atherosclerosis	0.000527	0.0143	CbGeAlD
Dinoprostone—Flushing—Niacin—atherosclerosis	0.000523	0.00572	CcSEcCtD
Dinoprostone—Flushing—Pravastatin—atherosclerosis	0.000515	0.00564	CcSEcCtD
Dinoprostone—Muscle spasms—Simvastatin—atherosclerosis	0.000514	0.00562	CcSEcCtD
Dinoprostone—SLC22A11—liver—atherosclerosis	0.000513	0.0139	CbGeAlD
Dinoprostone—Angiopathy—Niacin—atherosclerosis	0.000511	0.0056	CcSEcCtD
Dinoprostone—Chills—Niacin—atherosclerosis	0.000506	0.00553	CcSEcCtD
Dinoprostone—Vision blurred—Simvastatin—atherosclerosis	0.000503	0.00551	CcSEcCtD
Dinoprostone—Arrhythmia—Niacin—atherosclerosis	0.000503	0.00551	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000501	0.00548	CcSEcCtD
Dinoprostone—SLC22A7—liver—atherosclerosis	0.000501	0.0136	CbGeAlD
Dinoprostone—Tremor—Simvastatin—atherosclerosis	0.000501	0.00548	CcSEcCtD
Dinoprostone—Chills—Pravastatin—atherosclerosis	0.000498	0.00545	CcSEcCtD
Dinoprostone—Arrhythmia—Pravastatin—atherosclerosis	0.000496	0.00542	CcSEcCtD
Dinoprostone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000494	0.00541	CcSEcCtD
Dinoprostone—Cough—Ezetimibe—atherosclerosis	0.000489	0.00535	CcSEcCtD
Dinoprostone—Myalgia—Lovastatin—atherosclerosis	0.000486	0.00532	CcSEcCtD
Dinoprostone—Chest pain—Lovastatin—atherosclerosis	0.000486	0.00532	CcSEcCtD
Dinoprostone—Arthralgia—Lovastatin—atherosclerosis	0.000486	0.00532	CcSEcCtD
Dinoprostone—Hypertension—Ezetimibe—atherosclerosis	0.000484	0.00529	CcSEcCtD
Dinoprostone—Tension—Niacin—atherosclerosis	0.000481	0.00527	CcSEcCtD
Dinoprostone—Chest pain—Ezetimibe—atherosclerosis	0.000477	0.00522	CcSEcCtD
Dinoprostone—Arthralgia—Ezetimibe—atherosclerosis	0.000477	0.00522	CcSEcCtD
Dinoprostone—Myalgia—Ezetimibe—atherosclerosis	0.000477	0.00522	CcSEcCtD
Dinoprostone—Tension—Pravastatin—atherosclerosis	0.000474	0.00519	CcSEcCtD
Dinoprostone—Muscle spasms—Niacin—atherosclerosis	0.000472	0.00516	CcSEcCtD
Dinoprostone—Pain—Rosuvastatin—atherosclerosis	0.00047	0.00515	CcSEcCtD
Dinoprostone—SLCO2B1—adipose tissue—atherosclerosis	0.00047	0.0127	CbGeAlD
Dinoprostone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000466	0.0051	CcSEcCtD
Dinoprostone—SLCO3A1—liver—atherosclerosis	0.000465	0.0126	CbGeAlD
Dinoprostone—Muscle spasms—Pravastatin—atherosclerosis	0.000464	0.00508	CcSEcCtD
Dinoprostone—Vision blurred—Niacin—atherosclerosis	0.000462	0.00506	CcSEcCtD
Dinoprostone—SLCO2A1—liver—atherosclerosis	0.00046	0.0125	CbGeAlD
Dinoprostone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000457	0.005	CcSEcCtD
Dinoprostone—Vision blurred—Pravastatin—atherosclerosis	0.000455	0.00498	CcSEcCtD
Dinoprostone—Myalgia—Simvastatin—atherosclerosis	0.000455	0.00498	CcSEcCtD
Dinoprostone—Arthralgia—Simvastatin—atherosclerosis	0.000455	0.00498	CcSEcCtD
Dinoprostone—Chest pain—Simvastatin—atherosclerosis	0.000455	0.00498	CcSEcCtD
Dinoprostone—Tremor—Pravastatin—atherosclerosis	0.000453	0.00495	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00045	0.00492	CcSEcCtD
Dinoprostone—SLC22A1—adipose tissue—atherosclerosis	0.000449	0.0122	CbGeAlD
Dinoprostone—Syncope—Niacin—atherosclerosis	0.00044	0.00481	CcSEcCtD
Dinoprostone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000436	0.00477	CcSEcCtD
Dinoprostone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000435	0.00476	CcSEcCtD
Dinoprostone—Loss of consciousness—Niacin—atherosclerosis	0.000431	0.00472	CcSEcCtD
Dinoprostone—Cough—Niacin—atherosclerosis	0.000428	0.00468	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000425	0.00465	CcSEcCtD
Dinoprostone—SLCO4A1—liver—atherosclerosis	0.000423	0.0115	CbGeAlD
Dinoprostone—CYP19A1—adipose tissue—atherosclerosis	0.000422	0.0114	CbGeAlD
Dinoprostone—Cough—Pravastatin—atherosclerosis	0.000421	0.00461	CcSEcCtD
Dinoprostone—ABCC5—liver—atherosclerosis	0.000421	0.0114	CbGeAlD
Dinoprostone—Paraesthesia—Lovastatin—atherosclerosis	0.000419	0.00458	CcSEcCtD
Dinoprostone—Arthralgia—Niacin—atherosclerosis	0.000418	0.00457	CcSEcCtD
Dinoprostone—Myalgia—Niacin—atherosclerosis	0.000418	0.00457	CcSEcCtD
Dinoprostone—Hypertension—Pravastatin—atherosclerosis	0.000417	0.00456	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000417	0.00456	CcSEcCtD
Dinoprostone—ABCC4—adipose tissue—atherosclerosis	0.000416	0.0113	CbGeAlD
Dinoprostone—Dyspnoea—Lovastatin—atherosclerosis	0.000416	0.00455	CcSEcCtD
Dinoprostone—Chest pain—Pravastatin—atherosclerosis	0.000411	0.0045	CcSEcCtD
Dinoprostone—Myalgia—Pravastatin—atherosclerosis	0.000411	0.0045	CcSEcCtD
Dinoprostone—Arthralgia—Pravastatin—atherosclerosis	0.000411	0.0045	CcSEcCtD
Dinoprostone—Paraesthesia—Ezetimibe—atherosclerosis	0.000411	0.00449	CcSEcCtD
Dinoprostone—Dyspnoea—Ezetimibe—atherosclerosis	0.000408	0.00446	CcSEcCtD
Dinoprostone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000405	0.00444	CcSEcCtD
Dinoprostone—Anaphylactic shock—Niacin—atherosclerosis	0.0004	0.00438	CcSEcCtD
Dinoprostone—Pain—Lovastatin—atherosclerosis	0.000399	0.00436	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000397	0.00435	CcSEcCtD
Dinoprostone—Asthenia—Rosuvastatin—atherosclerosis	0.000395	0.00432	CcSEcCtD
Dinoprostone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000394	0.00431	CcSEcCtD
Dinoprostone—Shock—Niacin—atherosclerosis	0.000394	0.00431	CcSEcCtD
Dinoprostone—Paraesthesia—Simvastatin—atherosclerosis	0.000391	0.00428	CcSEcCtD
Dinoprostone—Pain—Ezetimibe—atherosclerosis	0.000391	0.00428	CcSEcCtD
Dinoprostone—Tachycardia—Niacin—atherosclerosis	0.000391	0.00428	CcSEcCtD
Dinoprostone—Dyspnoea—Simvastatin—atherosclerosis	0.000389	0.00425	CcSEcCtD
Dinoprostone—Hyperhidrosis—Niacin—atherosclerosis	0.000387	0.00424	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000381	0.00417	CcSEcCtD
Dinoprostone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000381	0.00417	CcSEcCtD
Dinoprostone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000376	0.00412	CcSEcCtD
Dinoprostone—Hypotension—Niacin—atherosclerosis	0.000374	0.00409	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000374	0.00409	CcSEcCtD
Dinoprostone—Pain—Simvastatin—atherosclerosis	0.000373	0.00408	CcSEcCtD
Dinoprostone—SLCO1B1—liver—atherosclerosis	0.000373	0.0101	CbGeAlD
Dinoprostone—Body temperature increased—Lovastatin—atherosclerosis	0.000368	0.00403	CcSEcCtD
Dinoprostone—Abdominal pain—Lovastatin—atherosclerosis	0.000368	0.00403	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000365	0.00399	CcSEcCtD
Dinoprostone—Dizziness—Rosuvastatin—atherosclerosis	0.000364	0.00398	CcSEcCtD
Dinoprostone—Abdominal pain—Ezetimibe—atherosclerosis	0.000361	0.00396	CcSEcCtD
Dinoprostone—Body temperature increased—Ezetimibe—atherosclerosis	0.000361	0.00396	CcSEcCtD
Dinoprostone—Paraesthesia—Niacin—atherosclerosis	0.000359	0.00393	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000359	0.00393	CcSEcCtD
Dinoprostone—Dyspnoea—Niacin—atherosclerosis	0.000357	0.00391	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000357	0.0039	CcSEcCtD
Dinoprostone—Paraesthesia—Pravastatin—atherosclerosis	0.000354	0.00387	CcSEcCtD
Dinoprostone—Dyspnoea—Pravastatin—atherosclerosis	0.000351	0.00385	CcSEcCtD
Dinoprostone—Rash—Rosuvastatin—atherosclerosis	0.000347	0.0038	CcSEcCtD
Dinoprostone—Dermatitis—Rosuvastatin—atherosclerosis	0.000346	0.00379	CcSEcCtD
Dinoprostone—Abdominal pain—Simvastatin—atherosclerosis	0.000345	0.00377	CcSEcCtD
Dinoprostone—Body temperature increased—Simvastatin—atherosclerosis	0.000345	0.00377	CcSEcCtD
Dinoprostone—Headache—Rosuvastatin—atherosclerosis	0.000345	0.00377	CcSEcCtD
Dinoprostone—Hypersensitivity—Lovastatin—atherosclerosis	0.000343	0.00376	CcSEcCtD
Dinoprostone—Pain—Niacin—atherosclerosis	0.000342	0.00375	CcSEcCtD
Dinoprostone—Pain—Pravastatin—atherosclerosis	0.000337	0.00369	CcSEcCtD
Dinoprostone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000337	0.00369	CcSEcCtD
Dinoprostone—Asthenia—Lovastatin—atherosclerosis	0.000334	0.00366	CcSEcCtD
Dinoprostone—SLCO2B1—liver—atherosclerosis	0.000329	0.00893	CbGeAlD
Dinoprostone—Asthenia—Ezetimibe—atherosclerosis	0.000328	0.00359	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Niacin—atherosclerosis	0.000327	0.00358	CcSEcCtD
Dinoprostone—Nausea—Rosuvastatin—atherosclerosis	0.000327	0.00358	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000322	0.00353	CcSEcCtD
Dinoprostone—Hypersensitivity—Simvastatin—atherosclerosis	0.000321	0.00352	CcSEcCtD
Dinoprostone—Diarrhoea—Lovastatin—atherosclerosis	0.000319	0.00349	CcSEcCtD
Dinoprostone—Abdominal pain—Niacin—atherosclerosis	0.000316	0.00346	CcSEcCtD
Dinoprostone—Body temperature increased—Niacin—atherosclerosis	0.000316	0.00346	CcSEcCtD
Dinoprostone—SLC22A1—liver—atherosclerosis	0.000315	0.00853	CbGeAlD
Dinoprostone—Asthenia—Simvastatin—atherosclerosis	0.000313	0.00342	CcSEcCtD
Dinoprostone—Diarrhoea—Ezetimibe—atherosclerosis	0.000313	0.00342	CcSEcCtD
Dinoprostone—Body temperature increased—Pravastatin—atherosclerosis	0.000312	0.00341	CcSEcCtD
Dinoprostone—Abdominal pain—Pravastatin—atherosclerosis	0.000312	0.00341	CcSEcCtD
Dinoprostone—Dizziness—Lovastatin—atherosclerosis	0.000308	0.00337	CcSEcCtD
Dinoprostone—SLCO1A2—liver—atherosclerosis	0.000303	0.00822	CbGeAlD
Dinoprostone—Dizziness—Ezetimibe—atherosclerosis	0.000302	0.00331	CcSEcCtD
Dinoprostone—Diarrhoea—Simvastatin—atherosclerosis	0.000298	0.00326	CcSEcCtD
Dinoprostone—Vomiting—Lovastatin—atherosclerosis	0.000296	0.00324	CcSEcCtD
Dinoprostone—CYP19A1—liver—atherosclerosis	0.000296	0.00802	CbGeAlD
Dinoprostone—Hypersensitivity—Niacin—atherosclerosis	0.000295	0.00323	CcSEcCtD
Dinoprostone—Rash—Lovastatin—atherosclerosis	0.000294	0.00322	CcSEcCtD
Dinoprostone—Dermatitis—Lovastatin—atherosclerosis	0.000294	0.00321	CcSEcCtD
Dinoprostone—Headache—Lovastatin—atherosclerosis	0.000292	0.0032	CcSEcCtD
Dinoprostone—ABCC4—liver—atherosclerosis	0.000292	0.00791	CbGeAlD
Dinoprostone—Vomiting—Ezetimibe—atherosclerosis	0.000291	0.00318	CcSEcCtD
Dinoprostone—Hypersensitivity—Pravastatin—atherosclerosis	0.00029	0.00318	CcSEcCtD
Dinoprostone—Dizziness—Simvastatin—atherosclerosis	0.000288	0.00316	CcSEcCtD
Dinoprostone—Rash—Ezetimibe—atherosclerosis	0.000288	0.00315	CcSEcCtD
Dinoprostone—Dermatitis—Ezetimibe—atherosclerosis	0.000288	0.00315	CcSEcCtD
Dinoprostone—Asthenia—Niacin—atherosclerosis	0.000287	0.00314	CcSEcCtD
Dinoprostone—Headache—Ezetimibe—atherosclerosis	0.000286	0.00313	CcSEcCtD
Dinoprostone—Asthenia—Pravastatin—atherosclerosis	0.000283	0.0031	CcSEcCtD
Dinoprostone—Vomiting—Simvastatin—atherosclerosis	0.000277	0.00303	CcSEcCtD
Dinoprostone—Nausea—Lovastatin—atherosclerosis	0.000277	0.00303	CcSEcCtD
Dinoprostone—Rash—Simvastatin—atherosclerosis	0.000275	0.00301	CcSEcCtD
Dinoprostone—Dermatitis—Simvastatin—atherosclerosis	0.000275	0.00301	CcSEcCtD
Dinoprostone—Diarrhoea—Niacin—atherosclerosis	0.000274	0.003	CcSEcCtD
Dinoprostone—Headache—Simvastatin—atherosclerosis	0.000273	0.00299	CcSEcCtD
Dinoprostone—Nausea—Ezetimibe—atherosclerosis	0.000272	0.00297	CcSEcCtD
Dinoprostone—Diarrhoea—Pravastatin—atherosclerosis	0.00027	0.00295	CcSEcCtD
Dinoprostone—Dizziness—Niacin—atherosclerosis	0.000265	0.0029	CcSEcCtD
Dinoprostone—Dizziness—Pravastatin—atherosclerosis	0.000261	0.00285	CcSEcCtD
Dinoprostone—Nausea—Simvastatin—atherosclerosis	0.000259	0.00283	CcSEcCtD
Dinoprostone—Vomiting—Niacin—atherosclerosis	0.000255	0.00279	CcSEcCtD
Dinoprostone—Rash—Niacin—atherosclerosis	0.000252	0.00276	CcSEcCtD
Dinoprostone—Dermatitis—Niacin—atherosclerosis	0.000252	0.00276	CcSEcCtD
Dinoprostone—Headache—Niacin—atherosclerosis	0.000251	0.00274	CcSEcCtD
Dinoprostone—Vomiting—Pravastatin—atherosclerosis	0.000251	0.00274	CcSEcCtD
Dinoprostone—Rash—Pravastatin—atherosclerosis	0.000249	0.00272	CcSEcCtD
Dinoprostone—Dermatitis—Pravastatin—atherosclerosis	0.000248	0.00272	CcSEcCtD
Dinoprostone—Headache—Pravastatin—atherosclerosis	0.000247	0.0027	CcSEcCtD
Dinoprostone—Nausea—Niacin—atherosclerosis	0.000238	0.0026	CcSEcCtD
Dinoprostone—Nausea—Pravastatin—atherosclerosis	0.000234	0.00256	CcSEcCtD
Dinoprostone—CYP1A2—liver—atherosclerosis	0.000198	0.00537	CbGeAlD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	8.11e-06	5.78e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL6—atherosclerosis	8.1e-06	5.77e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—AKT1—atherosclerosis	8.1e-06	5.77e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—HMOX1—atherosclerosis	8.08e-06	5.76e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCL2—atherosclerosis	8.06e-06	5.74e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ABCA1—atherosclerosis	8.06e-06	5.74e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—INS—atherosclerosis	8.02e-06	5.71e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—INS—atherosclerosis	8.02e-06	5.71e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IGF1—atherosclerosis	7.92e-06	5.64e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTGS2—atherosclerosis	7.9e-06	5.62e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCL2—atherosclerosis	7.89e-06	5.62e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCL2—atherosclerosis	7.89e-06	5.62e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IGF1—atherosclerosis	7.76e-06	5.52e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IGF1—atherosclerosis	7.76e-06	5.52e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOB—atherosclerosis	7.74e-06	5.51e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HMGCR—atherosclerosis	7.72e-06	5.5e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MMP9—atherosclerosis	7.71e-06	5.49e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CG—atherosclerosis	7.63e-06	5.43e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NFKB1—atherosclerosis	7.63e-06	5.43e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—ALB—atherosclerosis	7.57e-06	5.39e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ALB—atherosclerosis	7.56e-06	5.38e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTM1—atherosclerosis	7.53e-06	5.36e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SERPINE1—atherosclerosis	7.52e-06	5.36e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—atherosclerosis	7.5e-06	5.34e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK8—atherosclerosis	7.5e-06	5.34e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—AKT1—atherosclerosis	7.48e-06	5.32e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—STAT3—atherosclerosis	7.43e-06	5.29e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—LPL—atherosclerosis	7.39e-06	5.26e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ABCA1—atherosclerosis	7.38e-06	5.26e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SERPINE1—atherosclerosis	7.37e-06	5.25e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SERPINE1—atherosclerosis	7.37e-06	5.25e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PPARG—atherosclerosis	7.36e-06	5.24e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—HMOX1—atherosclerosis	7.3e-06	5.2e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—NOS3—atherosclerosis	7.23e-06	5.15e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	7.23e-06	5.15e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—INS—atherosclerosis	7.22e-06	5.14e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GPX1—atherosclerosis	7.21e-06	5.14e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NOS3—atherosclerosis	7.18e-06	5.12e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MAPK3—atherosclerosis	7.09e-06	5.05e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NOS3—atherosclerosis	7.03e-06	5.01e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NOS3—atherosclerosis	7.03e-06	5.01e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CD36—atherosclerosis	7.02e-06	5e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOB—atherosclerosis	7e-06	4.98e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—atherosclerosis	6.92e-06	4.93e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—HMOX1—atherosclerosis	6.91e-06	4.92e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—atherosclerosis	6.88e-06	4.9e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ABCA1—atherosclerosis	6.88e-06	4.9e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCG1—atherosclerosis	6.88e-06	4.9e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—STAT3—atherosclerosis	6.85e-06	4.88e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTM1—atherosclerosis	6.81e-06	4.85e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—LPL—atherosclerosis	6.68e-06	4.76e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—MTHFR—atherosclerosis	6.66e-06	4.74e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ALB—atherosclerosis	6.62e-06	4.72e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOB—atherosclerosis	6.62e-06	4.72e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—atherosclerosis	6.61e-06	4.71e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK3—atherosclerosis	6.55e-06	4.66e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARA—atherosclerosis	6.53e-06	4.65e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GPX1—atherosclerosis	6.52e-06	4.64e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FABP4—atherosclerosis	6.47e-06	4.6e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LCAT—atherosclerosis	6.47e-06	4.6e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTM1—atherosclerosis	6.44e-06	4.59e-05	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—AKT1—atherosclerosis	6.42e-06	4.57e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCL8—atherosclerosis	6.37e-06	4.54e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—atherosclerosis	6.35e-06	4.52e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CD36—atherosclerosis	6.35e-06	4.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOA4—atherosclerosis	6.35e-06	4.52e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—HMOX1—atherosclerosis	6.33e-06	4.51e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—NOS3—atherosclerosis	6.33e-06	4.51e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AGT—atherosclerosis	6.32e-06	4.5e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—LPL—atherosclerosis	6.32e-06	4.5e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—atherosclerosis	6.32e-06	4.5e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCL8—atherosclerosis	6.24e-06	4.44e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCL8—atherosclerosis	6.24e-06	4.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP7A1—atherosclerosis	6.23e-06	4.44e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOE—atherosclerosis	6.2e-06	4.41e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GPX1—atherosclerosis	6.17e-06	4.39e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—STAT3—atherosclerosis	6.16e-06	4.39e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—atherosclerosis	6.16e-06	4.38e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CAV1—atherosclerosis	6.14e-06	4.37e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOA1—atherosclerosis	6.13e-06	4.36e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOB—atherosclerosis	6.07e-06	4.32e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—atherosclerosis	6.06e-06	4.32e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—atherosclerosis	6.03e-06	4.29e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—atherosclerosis	6.03e-06	4.29e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—atherosclerosis	6.02e-06	4.28e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CD36—atherosclerosis	6.01e-06	4.28e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.94e-06	4.23e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—atherosclerosis	5.93e-06	4.22e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—atherosclerosis	5.93e-06	4.22e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HMOX1—atherosclerosis	5.9e-06	4.2e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTM1—atherosclerosis	5.9e-06	4.2e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARA—atherosclerosis	5.9e-06	4.2e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK3—atherosclerosis	5.88e-06	4.19e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—atherosclerosis	5.83e-06	4.15e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—atherosclerosis	5.79e-06	4.13e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—LPL—atherosclerosis	5.79e-06	4.13e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—atherosclerosis	5.76e-06	4.1e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP27A1—atherosclerosis	5.76e-06	4.1e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AGT—atherosclerosis	5.72e-06	4.07e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—atherosclerosis	5.71e-06	4.07e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NFKB1—atherosclerosis	5.7e-06	4.06e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—atherosclerosis	5.69e-06	4.05e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—atherosclerosis	5.68e-06	4.05e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.67e-06	4.04e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOB—atherosclerosis	5.65e-06	4.03e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GPX1—atherosclerosis	5.65e-06	4.03e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—atherosclerosis	5.64e-06	4.02e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—atherosclerosis	5.64e-06	4.02e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK8—atherosclerosis	5.61e-06	3.99e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOE—atherosclerosis	5.6e-06	3.99e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CG—atherosclerosis	5.59e-06	3.98e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—atherosclerosis	5.59e-06	3.98e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARA—atherosclerosis	5.58e-06	3.98e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NFKB1—atherosclerosis	5.58e-06	3.98e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NFKB1—atherosclerosis	5.58e-06	3.98e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CAV1—atherosclerosis	5.55e-06	3.95e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOA1—atherosclerosis	5.54e-06	3.94e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.53e-06	3.94e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CD36—atherosclerosis	5.5e-06	3.92e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTM1—atherosclerosis	5.5e-06	3.92e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK8—atherosclerosis	5.49e-06	3.91e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK8—atherosclerosis	5.49e-06	3.91e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—atherosclerosis	5.47e-06	3.9e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—atherosclerosis	5.47e-06	3.9e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOA2—atherosclerosis	5.46e-06	3.89e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	5.46e-06	3.89e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALOX15—atherosclerosis	5.46e-06	3.89e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	5.46e-06	3.89e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AGT—atherosclerosis	5.41e-06	3.85e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—LPL—atherosclerosis	5.4e-06	3.85e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARG—atherosclerosis	5.4e-06	3.84e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCG5—atherosclerosis	5.4e-06	3.84e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.39e-06	3.84e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOE—atherosclerosis	5.3e-06	3.77e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—INS—atherosclerosis	5.29e-06	3.77e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GPX1—atherosclerosis	5.27e-06	3.75e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CAV1—atherosclerosis	5.25e-06	3.74e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOA1—atherosclerosis	5.24e-06	3.73e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—atherosclerosis	5.22e-06	3.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LPA—atherosclerosis	5.21e-06	3.71e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—atherosclerosis	5.19e-06	3.69e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—atherosclerosis	5.18e-06	3.69e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CD36—atherosclerosis	5.13e-06	3.65e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—atherosclerosis	5.12e-06	3.65e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARA—atherosclerosis	5.12e-06	3.64e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—atherosclerosis	5.07e-06	3.61e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—atherosclerosis	5.07e-06	3.61e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CG—atherosclerosis	5.05e-06	3.6e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BGN—atherosclerosis	5.05e-06	3.59e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—atherosclerosis	5.02e-06	3.57e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—atherosclerosis	5.02e-06	3.57e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.01e-06	3.57e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOA5—atherosclerosis	5e-06	3.56e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AGT—atherosclerosis	4.96e-06	3.53e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK3—atherosclerosis	4.9e-06	3.49e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARG—atherosclerosis	4.88e-06	3.47e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—atherosclerosis	4.86e-06	3.46e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOE—atherosclerosis	4.86e-06	3.46e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—atherosclerosis	4.85e-06	3.46e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.85e-06	3.46e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CAV1—atherosclerosis	4.81e-06	3.43e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	4.81e-06	3.43e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOA1—atherosclerosis	4.8e-06	3.42e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK3—atherosclerosis	4.79e-06	3.41e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK3—atherosclerosis	4.79e-06	3.41e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—atherosclerosis	4.79e-06	3.41e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—atherosclerosis	4.79e-06	3.41e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—INS—atherosclerosis	4.78e-06	3.41e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	4.78e-06	3.41e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARA—atherosclerosis	4.77e-06	3.4e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.75e-06	3.39e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—atherosclerosis	4.75e-06	3.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.71e-06	3.36e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.7e-06	3.35e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—atherosclerosis	4.65e-06	3.31e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—atherosclerosis	4.65e-06	3.31e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALOX5—atherosclerosis	4.64e-06	3.31e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NOS3—atherosclerosis	4.64e-06	3.31e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AGT—atherosclerosis	4.62e-06	3.29e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARG—atherosclerosis	4.62e-06	3.29e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—INS—atherosclerosis	4.53e-06	3.22e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOE—atherosclerosis	4.53e-06	3.22e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CAV1—atherosclerosis	4.48e-06	3.19e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOA1—atherosclerosis	4.47e-06	3.19e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—atherosclerosis	4.42e-06	3.15e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—atherosclerosis	4.39e-06	3.12e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CG—atherosclerosis	4.38e-06	3.12e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—atherosclerosis	4.3e-06	3.06e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.29e-06	3.06e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—atherosclerosis	4.25e-06	3.02e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARG—atherosclerosis	4.23e-06	3.01e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NOS3—atherosclerosis	4.2e-06	2.99e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NAMPT—atherosclerosis	4.17e-06	2.97e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—atherosclerosis	4.15e-06	2.96e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—INS—atherosclerosis	4.15e-06	2.95e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.14e-06	2.95e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LIPC—atherosclerosis	4.14e-06	2.95e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOC3—atherosclerosis	4.11e-06	2.93e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LDLR—atherosclerosis	4.09e-06	2.91e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CG—atherosclerosis	4.08e-06	2.91e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CETP—atherosclerosis	3.99e-06	2.84e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NOS3—atherosclerosis	3.97e-06	2.83e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—atherosclerosis	3.97e-06	2.83e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARG—atherosclerosis	3.94e-06	2.81e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—INS—atherosclerosis	3.87e-06	2.75e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—atherosclerosis	3.84e-06	2.73e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SCARB1—atherosclerosis	3.82e-06	2.72e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—atherosclerosis	3.8e-06	2.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.72e-06	2.65e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NOS3—atherosclerosis	3.64e-06	2.59e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—atherosclerosis	3.63e-06	2.59e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMGCR—atherosclerosis	3.61e-06	2.57e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—atherosclerosis	3.58e-06	2.55e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—atherosclerosis	3.54e-06	2.52e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—atherosclerosis	3.5e-06	2.5e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—atherosclerosis	3.5e-06	2.5e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NOS3—atherosclerosis	3.39e-06	2.41e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—atherosclerosis	3.33e-06	2.37e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—atherosclerosis	3.32e-06	2.37e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—atherosclerosis	3.3e-06	2.35e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.26e-06	2.32e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—atherosclerosis	3.23e-06	2.3e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—atherosclerosis	3.23e-06	2.3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCA1—atherosclerosis	3.22e-06	2.29e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—atherosclerosis	3.1e-06	2.21e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—atherosclerosis	2.91e-06	2.07e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMOX1—atherosclerosis	2.76e-06	1.97e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOB—atherosclerosis	2.65e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.57e-06	1.83e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LPL—atherosclerosis	2.53e-06	1.8e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPX1—atherosclerosis	2.46e-06	1.76e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CD36—atherosclerosis	2.4e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.27e-06	1.62e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARA—atherosclerosis	2.23e-06	1.59e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AGT—atherosclerosis	2.16e-06	1.54e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—atherosclerosis	2.13e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOE—atherosclerosis	2.12e-06	1.51e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CAV1—atherosclerosis	2.1e-06	1.49e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOA1—atherosclerosis	2.09e-06	1.49e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—atherosclerosis	1.93e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.91e-06	1.36e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARG—atherosclerosis	1.84e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—atherosclerosis	1.82e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—INS—atherosclerosis	1.81e-06	1.29e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—atherosclerosis	1.67e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—atherosclerosis	1.66e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NOS3—atherosclerosis	1.59e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—atherosclerosis	1.56e-06	1.11e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.45e-06	1.03e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—atherosclerosis	7.29e-07	5.19e-06	CbGpPWpGaD
